# Analgesia for 2nd Trimester Termination of Pregnancy

> **NCT01563835** · NA · TERMINATED · sponsor: **Samuel Lunenfeld Research Institute, Mount Sinai Hospital** · enrollment: 42 (actual)

## Conditions studied

- Pain

## Interventions

- **DRUG:** bupivacaine, fentanyl
- **DRUG:** fentanyl

## Key facts

- **NCT ID:** NCT01563835
- **Lead sponsor:** Samuel Lunenfeld Research Institute, Mount Sinai Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-03
- **Primary completion:** 2014-01
- **Final completion:** 2014-01
- **Target enrollment:** 42 (ACTUAL)
- **Why stopped:** Recruitment difficulty
- **Last updated:** 2014-10-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01563835

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01563835, "Analgesia for 2nd Trimester Termination of Pregnancy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01563835. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*